Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans.
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects of dietary supplementation with marine oils on vascular reactivity in human forearm resistance arteries were studied. Healthy male adults (six to nine subjects per group) were given either maxEPA capsules (content: eicosapentaenoic acid, 0.178 g/g; docosahexaenoic acid, 0.116 g/g) at doses of 20, 10, or 5 g/day or placebo capsules at 20 g/day for 28 days. Capsule compliance was confirmed by measurement of platelet membrane incorporation of n-3 fatty acids. Blood pressure was not affected by either maxEPA or placebo. The influence of treatment interventions on forearm vasoconstrictive responses to local infusions of angiotensin II and norepinephrine was examined using venous occlusion plethysmography before and after treatment. Responses to both agonists were significantly suppressed by 20 g/day maxEPA (slopes before and after maxEPA, respectively: angiotensin II, 3.34 and 0.89; norepinephrine, 0.91 and 0.41). When analyzed as difference in area under the dose-response curves, the suppressive effects of maxEPA were clearly dose dependent (angiotensin II: 20 g area reduced by 72%, 10 g by 67%, 5 g by 33%). Similarly, responses to norepinephrine were dose-dependently suppressed by maxEPA (20 g area reduced by 61%, 10 g by 63%, and 5 g by 33%). Placebo had no effect on the responses to either constrictor. The responses to both agonists returned to preoil levels after 2 months' discontinuation of 20 g/day maxEPA. We conclude that the suppressive effects of marine oils on vascular reactivity may, in part, contribute to their cardioprotective influence in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Cited by
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Bucher, H. C., Hengstler, P., Schindler, C., & Meier, G. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01114-7 · Cited by 823
Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials
Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R. T., & Kok, F. J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00010 · Cited by 700
n–3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored
CALDER, P. C. (2004) · Clinical Science · doi:10.1042/cs20040119 · Cited by 560
Fish Intake and Risk of Incident Atrial Fibrillation
Mozaffarian, D., Psaty, B. M., Rimm, E. B., Lemaitre, R. N., Burke, G. L., Lyles, M. F., Lefkowitz, D., & Siscovick, D. S. (2004) · Circulation · doi:10.1161/01.cir.0000138154.00779.a5 · Cited by 456
Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., & Beilin, L. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.253 · Cited by 407
The health effects of dietary unsaturated fatty acids
Lunn, J., & Theobald, H. E. (2006) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2006.00571.x · Cited by 401
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.003 · Cited by 370
Mori, T. A., Watts, G. F., Burke, V., Hilme, E., Puddey, I. B., & Beilin, L. J. (2000) · Circulation · doi:10.1161/01.cir.102.11.1264 · Cited by 360
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348
Miller, P. E., Van Elswyk, M., & Alexander, D. D. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu024 · Cited by 338
Jani, B., & Rajkumar, C. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.036053 · Cited by 308
Dietary α-linolenic acid and health-related outcomes: a metabolic perspective
Burdge, G. C., & Calder, P. C. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2005113 · Cited by 281
“2004), vascular reactivity (Chin et al. 1993; McVeigh et al. 1994; Goode et al. 1997; Tagawa et al. 1999), and inflammation (for reviews, see Calder, 2001, 2002, 2003, 2005).”
Fish Intake and Risk of Incident Heart Failure
Mozaffarian, D., Bryson, C. L., Lemaitre, R. N., Burke, G. L., & Siscovick, D. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.038 · Cited by 276
Fish oil and cardiovascular disease: lipids and arterial function
Nestel, P. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.228s · Cited by 265
Self-citationNestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., & Raederstorff, D. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.326 · Cited by 263
Self-citationThe differential effects of EPA and DHA on cardiovascular risk factors
Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247
Fish, Mercury, Selenium and Cardiovascular Risk: Current Evidence and Unanswered Questions
Mozaffarian, D. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6061894 · Cited by 182
“Consumption of fish or fish oil favorably affects several cardiovascular risk factors (Figure 1) [13-24].”
BackgroundEffect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study
Caslake, M. J., Miles, E. A., Kofler, B. M., Lietz, G., Curtis, P., Armah, C. K., Kimber, A. C., Grew, J. P., Farrell, L., Stannard, J., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.618 · Cited by 162
Mozaffarian, D., Gottdiener, J. S., & Siscovick, D. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.025 · Cited by 134
Zhang, X., Ritonja, J. A., Zhou, N., Chen, B. E., & Li, X. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.025071 · Cited by 122
How do fish oils affect vascular function?
Chin, J. P. F., & Dart, A. M. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01959.x · Cited by 77
Self-citation
Metadata
- Authors
- Chin, J. P., Gust, A. P., Nestel, P. J., & Dart, A. M.
- Venue
- Hypertension
- Published
- 1993-01
- Volume
- 21
- Issue
- 1
- Pages
- 22-28
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1999356575
- Cited by
- 154
- References
- 1
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.